The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125053642 12505364 2 F 20160618 20160705 20160628 20160715 EXP US-JNJFOC-20160623970 PHARMACYCLICS 72.00 YR E M Y 0.00000 20160715 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125053642 12505364 1 SS IBRUTINIB IBRUTINIB 1 Unknown Y N 0 CAPSULE
125053642 12505364 2 SS IBRUTINIB IBRUTINIB 1 Unknown Y N 0 CAPSULE
125053642 12505364 3 SS IBRUTINIB IBRUTINIB 1 Unknown Y N 0 CAPSULE
125053642 12505364 4 PS IBRUTINIB IBRUTINIB 1 Unknown Y N 205552 CAPSULE
125053642 12505364 5 SS FLUDARABINE FLUDARABINE PHOSPHATE 1 Intravenous (not otherwise specified) Y N 0 INTRAVENOUS INFUSION
125053642 12505364 6 SS FLUDARABINE FLUDARABINE PHOSPHATE 1 Intravenous (not otherwise specified) Y N 0 INTRAVENOUS INFUSION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125053642 12505364 1 Chronic lymphocytic leukaemia
125053642 12505364 2 Chronic lymphocytic leukaemia
125053642 12505364 3 Therapy naive
125053642 12505364 4 Therapy naive
125053642 12505364 5 Chronic lymphocytic leukaemia
125053642 12505364 6 Therapy naive

Outcome of event

Event ID CASEID OUTC COD
125053642 12505364 OT
125053642 12505364 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125053642 12505364 Acute kidney injury
125053642 12505364 Dehydration
125053642 12505364 Haemoglobin decreased
125053642 12505364 Hyperbilirubinaemia
125053642 12505364 Sepsis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125053642 12505364 1 20160130 20160618 0
125053642 12505364 2 20160624 0
125053642 12505364 3 20160130 20160618 0
125053642 12505364 4 20160624 0
125053642 12505364 5 20160130 20160618 0
125053642 12505364 6 20160130 20160618 0